Federal legal notice: CBD legal status under federal law depends on current sources. This guide reports United States federal sources as checked on September 3, 2026. It does not decide whether a product, sale, shipment, trip, prescription, or possession is lawful for any person. State, tribal, local, FDA, DEA, customs, carrier, workplace, and venue rules may differ. This is not legal advice.
CBD legal status cannot be decided from the word “CBD” alone. Product contents, source, form, intended use, date, and jurisdiction all matter. H.R. 6500 became law on September 2, 2026 and temporarily holds back most Section 781 hemp-definition changes until December 11, 2026. A narrower rule for products containing cannabinoids that cannot occur naturally in cannabis still follows the November 12 timeline.
How CBD Legal Status Is Determined
A hemp classification under the Agricultural Marketing Act does not automatically make every finished CBD product lawful under every federal statute. The federal hemp definition addresses whether covered cannabis material is excluded from the Controlled Substances Act definition of marijuana. FDA rules separately govern foods, dietary supplements, drugs, cosmetics, animal products, labeling, and disease claims.
Only one prescription CBD drug, Epidiolex, has FDA approval. FDA states that CBD products generally may not be marketed as dietary supplements and that food with added CBD may not be introduced into interstate commerce under the agency’s current interpretation of federal law.
Read the Two Federal Dates Separately
| Period | Federal Hemp-Definition Position | Consumer Check |
|---|---|---|
| Through November 11, 2026 | The current definition generally uses no more than 0.3% delta-9 THC on a dry-weight basis for the plant and covered derivatives. | Check the exact product, batch report, current state rules, and separate FDA restrictions. |
| November 12 through December 10, 2026 | Under H.R. 6500 Section 2019, Section 781’s amendments apply during this interval only to the two named product categories involving cannabinoids that cannot be naturally produced by Cannabis sativa L. | Do not call this a full postponement. Products involving non-naturally-producible cannabinoids remain on the November track. |
| December 11, 2026 onward | Section 781’s wider hemp-definition changes are scheduled to apply unless a later federal law changes the result. | Recheck enacted federal text near the date. Do not rely on a proposal, press quote, or old label. |
H.R. 6500 does not repeal Section 781. Its Section 2019 temporarily limits which Section 781 amendments apply before December 11.
Know What Section 781 Changes
Public Law 119-37 was enacted November 12, 2025. Section 781 was written to take effect 365 days later. Among its changes, the provision:
- uses a total-tetrahydrocannabinol framework for plant material, including tetrahydrocannabinolic acid;
- excludes intermediate and final products containing cannabinoids that cannot be naturally produced by cannabis;
- addresses cannabinoids capable of natural production but synthesized or manufactured outside the plant; and
- sets a 0.4 milligram combined total per-container threshold for total tetrahydrocannabinols and other cannabinoids HHS identifies or that are marketed as having similar effects.
The wording is technical. A package claim such as “hemp derived,” “full spectrum,” or “federally compliant” does not establish that a product fits the statute.
Separate Hemp Status From FDA Product Rules
| Question | Federal Source to Check | Why It Is Separate |
|---|---|---|
| Does the material fit the federal hemp definition? | Agricultural Marketing Act, Controlled Substances Act, Public Law 119-37, and H.R. 6500 | This determines whether covered cannabis material is excluded from the federal marijuana definition. |
| Can CBD be added to food sold in interstate commerce? | FDA food and cannabis-derived product guidance | Food-additive and drug-exclusion rules are not answered by hemp status. |
| Can a retail CBD product be labeled as a dietary supplement? | FDA dietary-supplement position | FDA states that the drug-exclusion provisions apply to CBD under the agency’s current position. |
| Can a product claim to treat disease? | Federal Food, Drug, and Cosmetic Act and FDA enforcement records | Disease-treatment claims can make a product an unapproved drug. |
| Is the product lawful in a state or city? | Current state, tribal, and local sources | Local rules can be stricter or use different categories, limits, licensing, or age rules. |
Use a Product-Level Federal Check
- Identify the product form. Flower, oil, gummy, capsule, topical, vape, food, beverage, animal product, and drug products can trigger different rules.
- Identify the source and cannabinoid process. A label may not reveal whether a cannabinoid occurred naturally, was extracted, converted, synthesized, or manufactured outside the plant.
- Read the exact batch COA. Check delta-9 THC, THCA, total THC, other named cannabinoids, units, reporting limits, and container math.
- Check the date. November 12 and December 11 have different effects under the enacted 2026 text.
- Check FDA status. Product form, intended use, claims, and route of administration matter.
- Check state and local rules. Federal hemp status is not a national permission slip.
- Check the setting. Travel, workplace testing, sports, schools, housing, federal property, carriers, and contracts can add separate rules.
Start with the CBD buying checklist, then use How to Read a CBD COA for the batch evidence.
Do Not Rely on These Shortcuts
- “It is CBD, so it is legal.”
- “It came from hemp, so FDA rules do not apply.”
- “The label says 0.3%, so every federal and state rule is satisfied.”
- “Congress delayed the whole law.”
- “A bill was introduced, so the rule changed.”
- “A COA proves the product is legal everywhere.”
For the dated event record, use the Federal and State CBD Update Log. For the current short-term alert, read the H.R. 6500 hemp-law update.
Primary Sources
- White House: H.R. 6500 Signed into Law on September 2, 2026
- GovInfo: H.R. 6500 Senate-Passed Text, Including Section 2019
- GovInfo: Public Law 119-37, Including Section 781
- FDA: Regulation of Cannabis and Cannabis-Derived Products, Including CBD
Jurisdiction: United States federal law. Fact checked: September 3, 2026. Recheck the enacted text and responsible agency records before relying on this timeline.